Immuneering (IMRX) Shares Outstanding (Weighted Average) (2020 - 2024)
Historic Shares Outstanding (Weighted Average) for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $29.8 million.
- Immuneering's Shares Outstanding (Weighted Average) rose 196.67% to $29.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $29.8 million, marking a year-over-year increase of 196.67%. This contributed to the annual value of $28.4 million for FY2023, which is 769.21% up from last year.
- Per Immuneering's latest filing, its Shares Outstanding (Weighted Average) stood at $29.8 million for Q3 2024, which was up 196.67% from $29.7 million recorded in Q2 2024.
- Immuneering's 5-year Shares Outstanding (Weighted Average) high stood at $29.8 million for Q3 2024, and its period low was $5.0 million during Q2 2020.
- For the 5-year period, Immuneering's Shares Outstanding (Weighted Average) averaged around $20.2 million, with its median value being $26.4 million (2022).
- In the last 5 years, Immuneering's Shares Outstanding (Weighted Average) increased by 8.94% in 2021 and then skyrocketed by 43256.76% in 2022.
- Over the past 5 years, Immuneering's Shares Outstanding (Weighted Average) (Quarter) stood at $5.0 million in 2020, then soared by 175.0% to $13.6 million in 2021, then surged by 93.84% to $26.4 million in 2022, then increased by 7.69% to $28.4 million in 2023, then increased by 5.02% to $29.8 million in 2024.
- Its Shares Outstanding (Weighted Average) was $29.8 million in Q3 2024, compared to $29.7 million in Q2 2024 and $29.4 million in Q1 2024.